jdhmnovel Chapter 230 A 100 Billion Acquisition?
Chapter 230 A 100 Billion Acquisition?
……
Chen Xuan glanced at Qin Guoming.
Faced with the latter's attitude, his expression remained calm and he just nodded as a greeting.
"Mr. Chen, is it convenient now?"
"How about we find a place to sit down and chat slowly? Since you are a local, you can choose the place. I will follow the host's wishes." Qin Guoming remained enthusiastic despite Chen Xuan's cold attitude, and even tried his best to narrow the gap between the two.
He didn't mention anything about cooperation and only expressed his desire to communicate with Chen Xuan.
"Sorry, I don't have time."
"There's another experiment to be done soon, and we'll also have to follow up on the clinical trial tomorrow."
"If you have something to say, let's talk in the office. Try to keep it short so as not to waste Qin Dong's time."
Chen Xuan was very direct.
He didn't intend to be polite.
To him, this hypocritical communication was completely meaningless.
If you have something to say, say it. If not, go back.
As for eating or drinking tea, he had absolutely no interest in going with someone he didn't know well.
The most important thing is that he would not agree to cooperate with Qin Guoming. This meeting was purely to help Zhang Dapao repay a favor.
"Okay, Mr. Chen is quick to speak."
"I like communicating with people like Mr. Chen. Without being fussy about details, we can get things done more efficiently."
"Since Mr. Chen is busy with work, let's cut to the chase and talk directly in your office."
Qin Guoming smiled and nodded, his face still expressionless.
It seemed as if Chen Xuan's cold attitude had no effect on him at all, nor did it show any dissatisfaction at all.
……
Afterwards, the two of them also came to the office.
"Mr. Chen, I know you like tea."
"I don't have any special characteristics. My only hobby is collecting tea leaves, and I like communicating with tea lovers even more."
"This is the Dahongpao from the mother tree of Wuyi Mountain that I collected a while ago. I hope Mr. Chen can taste it."
After sitting opposite each other in the office, Qin Guoming immediately took out the gift he had prepared long ago.
This gift is not very expensive, but it can be said to be unique, extremely sincere, and very suitable as a gift.
It's not because it's expensive, but because it's scarce.
The kind of scarcity that 99% of rich people can't afford.
He was also very smart. He just mentioned this kind of tea casually without giving too much detailed introduction, and he didn't even mention the price.
This kind of tea only needs a name to let people know its meaning.
If you say it directly, it will seem very materialistic.
In fact, Chen Xuan did know this kind of tea.
Wuyishan Dahongpao is considered a very precious tea.
What's more, the word "mother tree" is added in front.
There are only six of them in the world, all of which are 300 years old. You can imagine how rare they are.
However, Chen Xuan simply ignored all of Qin Guoming's subtext.
Because he had no intention of accepting the tea at all.
He had no interest in how precious or rare this tea was.
"Mr. Qin, there's no need to be so polite."
"Let's talk about business first. Maybe the cooperation won't work out, and you'll lose some tea instead."
"The cooperation didn't go through, and I feel uncomfortable holding Chairman Qin's gift, so it's better to talk about business first."
Chen Xuan spoke directly, he didn't even look at the tea leaves from beginning to end.
Giving tea as a gift is indeed a thoughtful gesture. It is not very expensive for people like them, but it is also what they like.
"Okay, then let's talk about cooperation first."
"Wait until the cooperation is reached, and then we will slowly drink tea together with Mr. Chen." Seeing Chen Xuan's firm attitude, Qin Guoming could only say this.
He now realized that although the person in front of him was young, he was more stubborn than the average old stubborn person.
The most important thing is that he refuses to change her. No matter how humble and easy-going he is, the relationship between them remains so unfamiliar.
In this way, he knew that this cooperation would not be easy.
It is not easy to convince the other party to agree.
"Mr. Chen, this is what happened."
"We at Changfeng Group are very interested in your new drug and would like to cooperate with you."
After suffering setbacks repeatedly, Qin Guoming chose to speak frankly.
Since Chen Xuan didn't buy it, he got straight to the point.
"How to cooperate?" Chen Xuan asked casually.
He didn't want to cooperate, but it would be nice to hear the other party's ideas.
"We at Changfeng Group are willing to purchase the formula for 100 billion yuan."
"After that, we will have full ownership of the new drug, and Mr. Chen will receive 100 billion in cash."
Qin Guoming didn't want to test it slowly, he knew it was useless to test it now.
So, he simply raised the reserve price, skipping the bargaining process.
The price of 100 billion is definitely not the transaction price, but it can also let Chen Xuan see his sincerity, which is enough.
"Boss Qin, you're joking."
"I never set out to sell a new drug formula."
"And I don't think this new drug is worth only 100 billion!"
Chen Xuan sneered in his heart. Qin Guoming's plan was indeed a good one.
Now he wants to acquire the new drug formula for just 100 billion yuan, and even thinks he is very generous.
The previous liver cancer medicine sold 50 billion in the overseas market alone, plus the 30% profit in the domestic market, that’s a price of 100 billion.
Does he think that the market for lung cancer-specific drugs will be smaller than that for liver cancer-specific drugs?
What's more, he had no fame before, which made his medicine less credible. In this case, the price was naturally low.
But now he has already become famous and has a very high reputation in the entire medical community.
This added fame alone has caused the value of the drug formula to skyrocket, making it impossible to maintain the original price.
"I understand, and I also know what Mr. Chen thinks."
"Mr. Chen believes that new drugs have greater market potential and their value should increase. This is very reasonable, and I agree with him."
Qin Guoming nodded in agreement with Chen Xuan's words, then changed the subject.
"But Mr. Chen may not have considered that your liver cancer drug has been tested on patients. It's mature, reliable, and safe, so its value is naturally higher."
"But your lung cancer drug is different. It's just been put into clinical trials, so whether it's effective or safe is still a different story. The risks are still very high, so you can't just treat it like a mature formula and evaluate its value."
Chen Xuan could accept his words.
The specific drug for lung cancer has indeed just begun clinical trials, no matter how perfect the previous tests were.
However, problems may still occur in clinical trials, leading to the complete failure of the drug trial.
Although the probability of this risk is very small, it does not mean that it will not happen, and this will indeed lead to the value assessment of the drug.
Qin Guoming is not talking nonsense. There is indeed a basis for this. The value of a drug will indeed be very different if it has passed clinical trials or not.
The success rate of a drug from phase I clinical trials to approval for marketing is approximately 12.38 percent. If we exclude oncology drugs, the success rate is 20.6 percent!
According to incomplete statistics, there have been nearly 700 verification clinical trials in the past ten years. From the first phase of clinical trials to approval, the overall success rate in the oncology field is only 5.2%.
The specific drug for lung cancer is obviously an anti-tumor drug, and it is an extremely rare specific drug. Its success rate should be the lowest among all drugs.
However, judging from the series of experimental data released by Chen Xuan, the success rate of lung cancer-specific drugs passing clinical trials and being approved for marketing will definitely not be lower than 90%.
The clinical trials of some drugs are actually a matter of luck, and the pharmaceutical companies themselves are not sure about the results.
Failure is acceptable, but success can bring huge profits, which is why pharmaceutical companies will advance clinical trials.
However, for some drugs, pharmaceutical companies themselves are already very confident in their clinical trials and believe that the success rate is very high, which makes them more willing to invest more resources.
……